Imedex® is an industry leader in providing certified, independent continuing medical education to health care professionals.

March 23-24, 2018

New York, New York

Continuing Medical Education

Continuing Medical Education
Imedex®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This activity has been approved for AMA PRA Category 1 Credit™.

To enhance clinical outcomes in patients with gastrointestinal malignancies, healthcare professionals require expert review and analysis of pertinent clinical data to effectively identify and integrate optimal therapeutic regimens into everyday clinical practice. To narrow the identified practice gaps and underlying educational needs, the following objectives will be addressed within the educational activities.

    • Relate the use of biomarkers and molecular profiling to the selection of treatment for patients with for GI cancers
    • Evaluate new and emerging therapeutic regimens, including targeted and immune-based therapies, based on recently published data and findings from ongoing clinical trials for the treatment of non-metastatic and metastatic GI cancers
    • Assess effective therapeutic strategies for rare and difficult-to-treat diseases and for special patient populations
    • Analyze controversial issues related to the optimal management of different GI cancers